Drug Topics
JANUARY 13, 2023
A trio of leading hepatitis researchers survey the treatments in development for chronic hepatitis B. They end on a high note: That for the first time in 20 years, a cure is in sight.
PharmaVoice
JANUARY 13, 2023
Execs at JPM sound off on moves companies can make to survive the challenging market conditions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 13, 2023
Recommendations were made for patients to help relieve inflammation, itching and infections.
Pharmacy Times
JANUARY 13, 2023
Joseph Araujo, Chief Scientific Officer at Mindset Pharma, sat down to discuss natural vs. synthetic psychedelics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JANUARY 13, 2023
Your weekly roundup of the latest news from Drug Topics®.
Drug Store News
JANUARY 13, 2023
Retail pharmacy’s foray into clinical trial services is a no-brainer given their enhanced focus on improving patient outcomes in the communities they serve.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JANUARY 13, 2023
Jordan Sloshower, MD, MSc, explains his experience working in several clinical trials investigating psilocybin-assisted therapy.
STAT
JANUARY 13, 2023
Oscar Health has excelled at one thing in particular since its inception a decade ago: burning cash. The health insurance company did not plan to be profitable immediately. It was staking its future on the new Affordable Care Act marketplaces and had to grow quickly to compete with larger insurance carriers. Oscar organized its health insurance product through an app, promoted virtual care, advertised on New York subways, and then low-balled prices in certain markets to attract young, healthy pe
Pharmacy Times
JANUARY 13, 2023
“It's an honor to walk the last steps with someone, it is.”-Mary Lynn McPherson, PharmD, MA, MDE, FAAHPM.
Fierce Healthcare
JANUARY 13, 2023
California sues major PBMs, drugmakers over insulin prices. pminemyer. Fri, 01/13/2023 - 14:42.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JANUARY 13, 2023
Pharmacies should ensure appropriate monitoring procedures are in place to prevent contamination and exposure.
Fierce Healthcare
JANUARY 13, 2023
Optum expects to treat 4M in fully accountable, value-based models this year. pminemyer. Fri, 01/13/2023 - 07:31.
Pharmacy Times
JANUARY 13, 2023
Risk is highest for those who are obese or who have diabetes, investigator from Keck Medicine and the University of Southern California indicate.
Fierce Healthcare
JANUARY 13, 2023
KFF study details the challenges in addressing mental health in Medicaid. fdiamond. Fri, 01/13/2023 - 08:25.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JANUARY 13, 2023
Analysis indicates that for individuals older than aged 40 years, the risk is cumulative and greatest 1 to 2 years after use.
Fierce Healthcare
JANUARY 13, 2023
Following rapid expansion, Jefferson Health launches reorganization and, reportedly, layoffs. dmuoio. Fri, 01/13/2023 - 16:51.
Pharmacy Times
JANUARY 13, 2023
Counseling sessions offer opportunity to educate about appropriate dosing, potential adverse effects.
Drug Store News
JANUARY 13, 2023
Scotch Porter has been identified by IRI as the fastest growing male grooming brand within the U.S. beard and hair care market.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 13, 2023
Developments may soon impact clinical practice in hematology and oncology.
STAT
JANUARY 13, 2023
SAN FRANCISCO — Ginkgo Bioworks CEO Jason Kelly is here trying to convince the world’s largest drugmakers that yes, really, he actually can in fact help you. Kelly’s powers of persuasion, so potent for so long, have often come up short since Ginkgo went public in 2021. The company that raised $1.6 billion privately on the promise of engineering cells to make everyday products like perfumes and synthetic burgers — even one day an iPhone — has sunk like a rock on
Pharmacy Times
JANUARY 13, 2023
Zahra Mahmoudjafari, PharmD, BCOP, DPLA, opens a discussion surrounding chronic lymphocytic leukemia (CLL).
STAT
JANUARY 13, 2023
Access to treatment for addiction has long plagued U.S. health systems. Why? Two reasons: It is expensive, and the long-term value of addiction treatment is often disregarded by insurance companies and other payers. Its dirty little secret is that access to treatments that work are available to the few who can pay for it — as I once needed to do — while millions of Americans get substandard treatment or none at all.
Pharmacy Times
JANUARY 13, 2023
Analysis focuses on causal effects while accounting for other environmental and genetic factors, such as a family history and socioeconomic disadvantages.
STAT
JANUARY 13, 2023
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s authority to crack down on unfair business practices — and the shift could have major implications for its ongoing scrutiny of pharmacy benefit managers. The FTC has for years allowed mergers and business tactics that lower prices for consumers, even if they put small companies out of business.
European Pharmaceutical Review
JANUARY 13, 2023
AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for self-administration in a pre-filled, single-use auto-injector (AI) pen for severe asthma patients over 12 years. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca shared: “Tezspire is the first and only biologic approved in Europe for patients with severe asthma with no phenotype or biomarker limitation.”.
STAT
JANUARY 13, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to promenade extensively with the official mascot, catch up on our reading, and maybe hold a listening party with Mrs. Pharmalot (for now, the rotation will start with this and this ).
Drug Store News
JANUARY 13, 2023
For the month of December, HRG reviewed 39 products in the health category, 90 in the wellness sector and 137 items in the beauty category to see which ones stood out as Products to Watch.
STAT
JANUARY 13, 2023
Editor’s note: A live stream of the event will be embedded below at 1 p.m. ET. Relive the return to an in-person J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for next week.
Pharmaceutical Technology
JANUARY 13, 2023
The Biomedical Advanced Research and Development Authority (BARDA) has awarded a multi-year contract to the Sabin Vaccine Institute for developing and producing single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases. BARDA, part of the Administration for Strategic Preparedness and Response (ASPR) of the US Department of Health and Human Services, will initially invest around $35m for the production of up to 100,000 doses of the Ebola Sudan virus (ChAd3-SUDV) vaccine.
STAT
JANUARY 13, 2023
Marianne De Backer’s iPhone calendar is a solid block of green. De Backer, the head of strategy and business development at Bayer, has so many meetings on her schedule that there’s no telling where one ends and another begins. She hasn’t moved for much of the day from her spot in a Hilton conference room in San Francisco, decorated in shades of tan.
The Checkup by Singlecare
JANUARY 13, 2023
Alcohol can interact with many antibiotics, which can sometimes lead to serious side effects. However, some antibiotics, such as clindamycin, may be safer than others when mixed with alcohol. It’s unlikely that you’ll experience any severe problems while mixing clindamycin and alcohol, as long as you’re drinking in moderation. . According to the drug’s FDA label , there is no known clindamycin and alcohol interaction.
STAT
JANUARY 13, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Fierce Healthcare
JANUARY 13, 2023
JPM23's Health Tech Tidbits: Talkspace plots path to profitability, Veradigm invests in analytics company and Babylon CEO pushes back. hlandi. Fri, 01/13/2023 - 22:10.
Expert insights. Personalized for you.
467 
Let's personalize your content